サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1401824

ジェネリック注射医薬品受託製造市場：材料タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測

Generic Injectable Pharmaceutical Contract Manufacturing Market, By Material Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 303 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ジェネリック注射医薬品受託製造市場：材料タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2024年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ジェネリック注射医薬品受託製造市場規模は2022年に101億米ドルとなり、2023年から2030年にかけてCAGR 11.2%で拡大する見込みです。

ジェネリック注射医薬品受託製造市場-市場力学

製薬業界の製造需要、医薬品研究開発への投資拡大が市場需要を促進

同市場の拡大は主に、製薬業界の複雑な製造需要、医薬品研究開発（R&D）への投資拡大、先端技術への傾斜の高まり、特許切れ、コロナウイルスの大流行の影響に起因します。さらに、細胞治療や遺伝子治療、個別化医療に対する需要の高まり、高活性医薬品成分（HPAPI）や抗体薬物複合体（ADC）市場の急成長は、市場参入企業に大きなビジネスチャンスをもたらすと予想されます。費用対効果の高いジェネリック注射薬に対する需要が増え続けていることと、世界のヘルスケアシステムにおいてそのような医薬品が必要とされ続けていることが、この市場セグメントの成長を後押ししています。様々な利害関係者が協力して、規制基準を満たし、高品質の製造を確保し、入手しやすく手頃な価格の注射薬に対するヘルスケアのニーズに対応しています。

ジェネリック注射医薬品受託製造市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2023-2030年）に約11.2%のCAGRで毎年成長すると予測されています。

材料タイプセグメンテーションに基づくと、2022年には大型分子が最大市場シェアを示すと予測されました。

用途別では、2022年にオンコロジーが主要タイプに

地域別では、北米が2022年の売上高をリードしています。

ジェネリック注射医薬品受託製造市場-セグメンテーション分析：

世界のジェネリック注射医薬品受託製造市場は、材料タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は材料タイプによって2つのカテゴリーに分けられる：低分子と高分子です。材料タイプに基づくと、2022年の大幅な収益シェアは高分子セグメントによって占められました。米国では、オーダーメイド治療と精密医療に大きな注目が集まっていることが、高分子ジェネリック注射薬セグメントの成長に大きく寄与しています。さらに、バイオシミラーを含む製品上市の増加が、顕著にセグメントの拡大を支えています。例えば、2023年1月、アムジェンはヒュミラのバイオシミラーであるAMJEVITAを米国で発売しました。AMJEVITAは米国FDAによって承認されたヒュミラの最初のジェネリック医薬品であり、セグメントの成長を後押しすると期待される要因の一例です。

市場は用途別に7つのカテゴリーに分類される：がん領域、免疫領域、抗糖尿病領域、神経領域、循環器領域、呼吸器領域。神経、循環器、呼吸器、その他です。用途別では、がん領域が2022年に最大の収益シェアを確保しました。これは、がん治療用に調整されたジェネリック医薬品の発売が増加しているためです。数多くの受託製造業者が抗がん剤治療用のジェネリック注射剤の開発に注力しています。さらに、抗がん剤治療用のジェネリック医薬品はかなりのパイプラインが進行中であり、複数のジェネリック医薬品が市場へのイントロダクションを予定しています。

ジェネリック注射医薬品受託製造市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

ジェネリック注射医薬品受託製造市場-競合情勢：

ジェネリック注射医薬品受託製造市場の競争領域では、各社は多面的な戦略を採用し、その優位性と生存能力を確保しています。これらの企業は費用対効果を優先し、高品質のジェネリック注射薬を競争力のある価格で提供するために製造プロセスを綿密に微調整しています。品質とコンプライアンスは依然として譲れないものであり、cGMPのような厳格な規制基準を満たすことに確固たるコミットメントを持ち、最先端技術と近代的施設への投資を推進しています。サービスの多様化は、受託製造業者が様々な注射剤形式を網羅するために提供するサービスの幅を広げ、多様な顧客のニーズや市場の需要に対応するための重要な追求事項です。同時に、製造技術、製剤、ドラッグデリバリーシステムの進化を追求し、進化する状況の中で常に優位に立つために、研究開発に重点を置き、イノベーションを促進しています。戦略的パートナーシップと提携は、アウトソーシング・ソリューションを求める製薬会社との長期的な協力関係を育み、相互の成長と安定を確保しています。さらに、世界な展望に立った事業拡大構想が推進され、各地域の規制を遵守しつつ、より広範な市場に対応するため、各地域に製造拠点を設立しています。これらの戦略を組み合わせることで、製薬業界の複雑なダイナミクスを巧みに操り、ジェネリック注射剤の受託製造市場における競争力と持続的な成長を促進しています。

目次

第1章 ジェネリック注射医薬品受託製造市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ジェネリック注射医薬品受託製造の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ジェネリック注射医薬品受託製造業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ジェネリック注射医薬品受託製造市場：COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ジェネリック注射医薬品受託製造市場情勢

  • ジェネリック注射医薬品受託製造市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ジェネリック注射医薬品受託製造市場- 材料タイプ別

  • 概要
    • 材料タイプ別のセグメントシェア分析
    • 低分子
    • 高分子

第8章 ジェネリック注射医薬品受託製造市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • オンコロジー
    • 免疫学
    • 抗糖尿病薬
    • 神経内科
    • 心臓血管
    • 呼吸器系
    • その他

第9章 ジェネリック注射医薬品受託製造市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 大手製薬会社
    • 中小規模の製薬会社
    • ジェネリック医薬品会社
    • その他

第10章 ジェネリック注射医薬品受託製造市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ジェネリック注射医薬品受託製造業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Hikma Pharmaceuticals plc
    • Pfizer Inc.
    • Fresenius Kabi
    • Sandoz AG
    • Jubilant Pharma Limited
    • Baxter
    • PCI Pharma Services
    • Gland Pharma Limited（USA）
    • Dr. Reddy's Laboratories Ltd.
    • Grand River Aseptic Manufacturing
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Material Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Material Type
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User 2018-2030 (USD Million)
  • TABLE Generic Injectable Pharmaceutical Contract Manufacturing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Generic Injectable Pharmaceutical Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Material Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Generic Injectable Pharmaceutical Contract Manufacturing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Material Type segment market share analysis, 2022 & 2030
  • FIGURE Material Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Generic Injectable Pharmaceutical Contract Manufacturing Market share and leading players, 2022
  • FIGURE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market share and leading players, 2022
  • FIGURE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market share and leading players, 2022
  • FIGURE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market share and leading players, 2022
  • FIGURE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Generic Injectable Pharmaceutical Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Germany Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Generic Injectable Pharmaceutical Contract Manufacturing Market share analysis by country, 2022
  • FIGURE India Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Generic Injectable Pharmaceutical Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Brazil Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Generic Injectable Pharmaceutical Contract Manufacturing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Generic Injectable Pharmaceutical Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2032

REPORT HIGHLIGHT

Generic Injectable Pharmaceutical Contract Manufacturing Market size was valued at USD 10,100 Million in 2022, expanding at a CAGR of 11.2% from 2023 to 2030.

Generic Injectable Pharmaceutical Contract Manufacturing involves specialized contract manufacturers producing non-brand name injectable medications (e.g., intravenous, intramuscular, or subcutaneous routes) for pharmaceutical companies. This sector thrives on intricate manufacturing demands, investments in R&D, technological advancements, patent expirations, and pandemic impacts. It caters to cell and gene therapies, personalized medicines, HPAPI, and ADC markets. With a growing demand for cost-effective injectable drugs and an ongoing need in global healthcare, stakeholders collaborate to ensure regulatory compliance, quality production, and accessibility to affordable medications. Key segments include large molecule drugs (e.g., biosimilars) and oncology-focused products, witnessing continuous growth and innovation in the pharmaceutical market.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Market Dynamics

Manufacturing demands of the pharmaceutical industry, heightened investments in pharmaceutical research and development to propel market demand

The expansion of this market primarily stems from the intricate manufacturing demands of the pharmaceutical industry, heightened investments in pharmaceutical research and development (R&D), a growing inclination towards advanced technologies, patent expirations, and the impact of the coronavirus pandemic. Moreover, the rising demand for cell and gene therapies, personalized medicines, as well as the surge in the High-potency Active Pharmaceutical Ingredients (HPAPI) and Antibody-drug Conjugates (ADC) markets, is anticipated to present significant opportunities for market participants. The continued increase in demand for cost-effective generic injectable drugs, coupled with the ongoing necessity for such medications within global healthcare systems, propels the growth of this market segment. Various stakeholders collaborate to meet regulatory standards, ensure quality production, and address healthcare needs for accessible and affordable injectable medications.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2023-2030)

Based on Material Type segmentation, large molecule was predicted to show maximum market share in the year 2022

Based on application segmentation, Oncology was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Generic Injectable Pharmaceutical Contract Manufacturing Market- Segmentation Analysis:

The Global Generic Injectable Pharmaceutical Contract Manufacturing Market is segmented on the basis of Material Type, Application, End User, and Region.

The market is divided into two categories based on Material Type: Small Molecule and large Molecule. Based on material type, the significant revenue share in 2022 was held by the large molecule segment. The substantial focus on customized treatments and precision medicine significantly contributes to the growth of the large molecule generic injectable drugs segment in the U.S. Furthermore, the rise in product launches, including biosimilars, notably supports segment expansion. For instance, in January 2023, Amgen introduced AMJEVITA, a biosimilar to Humira, in the U.S. It was the first generic version of Humira approved by the U.S. FDA, indicative of factors expected to bolster segment growth.

The market is divided into seven categories based on application: Oncology, Immunology, Antidiabetic. Neurology, Cardiovascular, Respiratory and Others. Based on application, the oncology segment secured the largest revenue share in 2022. This is attributed to the increasing launch of generic products tailored for cancer treatment. Numerous contract manufacturers are concentrating on developing generic injectables for anti-cancer therapy. Additionally, a considerable pipeline of generic products for anti-cancer therapies is in progress, with several generic drugs slated for introduction into the market.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Generic Injectable Pharmaceutical Contract Manufacturing Market- Competitive Landscape:

In the competitive realm of the Generic Injectable Pharmaceutical Contract Manufacturing Market, companies employ multifaceted strategies to ensure their prominence and viability. These entities prioritize cost-effectiveness, meticulously fine-tuning manufacturing processes to deliver high-quality generic injectable medications at competitive prices. Quality and compliance remain non-negotiable, with a steadfast commitment to meeting stringent regulatory standards such as cGMP, driving investments in cutting-edge technologies and modern facilities. Diversification of services is a key pursuit, as contract manufacturers broaden their offerings to encompass various injectable formats, accommodating diverse client needs and market demands. Simultaneously, heavy emphasis on research and development fuels innovation, seeking advancements in manufacturing techniques, formulations, and drug delivery systems to stay ahead in the evolving landscape. Strategic partnerships and alliances are forged, fostering long-term collaborations with pharmaceutical firms seeking outsourcing solutions, ensuring mutual growth and stability. Moreover, a global outlook propels expansion initiatives, establishing manufacturing hubs in different regions to cater to a broader market while complying with regional regulations. Collectively, these strategies enable these companies to navigate the intricate dynamics of the pharmaceutical industry, driving competitiveness and sustained growth within the Generic Injectable Pharmaceutical Contract Manufacturing Market.

Recent Developments:

In March 2023, PCI Pharma Services, a biopharmaceutical contract manufacturer, disclosed plans to invest USD 50 million in expanding its sterile injectables facility situated in Rockford, Illinois.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Hikma Pharmaceuticals plc
  • Pfizer Inc.
  • Fresenius Kabi
  • Sandoz AG
  • Jubilant Pharma Limited
  • Baxter
  • PCI Pharma Services
  • Gland Pharma Limited (USA)
  • Dr. Reddy's Laboratories Ltd.
  • Grand River Aseptic Manufacturing
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY MATERIAL TYPE

  • Small Molecule
  • Large Molecule

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY APPLICATION

  • Oncology
  • Immunology
  • Antidiabetic
  • Neurology
  • Cardiovascular
  • Respiratory
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END USER

  • Big Pharmaceutical Companies
  • Small & Mid Sized Pharmaceutical Companies
  • Generic Pharmaceutical Companies
  • Others

GLOBAL GENERIC INJECTABLE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Generic Injectable Pharmaceutical Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Material Type
    • 2.1.2. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Application
    • 2.1.3. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by End User
    • 2.1.4. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Country
    • 2.1.5. Generic Injectable Pharmaceutical Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Generic Injectable Pharmaceutical Contract Manufacturing Key Market Trends

  • 3.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Generic Injectable Pharmaceutical Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Generic Injectable Pharmaceutical Contract Manufacturing Market Opportunities
  • 3.4. Generic Injectable Pharmaceutical Contract Manufacturing Market Future Trends

4. Generic Injectable Pharmaceutical Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Generic Injectable Pharmaceutical Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Generic Injectable Pharmaceutical Contract Manufacturing Market Landscape

  • 6.1. Generic Injectable Pharmaceutical Contract Manufacturing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Generic Injectable Pharmaceutical Contract Manufacturing Market - By Material Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Material Type, 2022 & 2030 (%)
    • 7.1.2. Small Molecule
    • 7.1.3. Large Molecule

8. Generic Injectable Pharmaceutical Contract Manufacturing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Oncology
    • 8.1.3. Immunology
    • 8.1.4. Antidiabetic
    • 8.1.5. Neurology
    • 8.1.6. Cardiovascular
    • 8.1.7. Respiratory
    • 8.1.8. Others

9. Generic Injectable Pharmaceutical Contract Manufacturing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Big Pharmaceutical Companies
    • 9.1.3. Small & Mid Sized Pharmaceutical Companies
    • 9.1.4. Generic Pharmaceutical Companies
    • 9.1.5. Others

10. Generic Injectable Pharmaceutical Contract Manufacturing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Generic Injectable Pharmaceutical Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Material Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Generic Injectable Pharmaceutical Contract Manufacturing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Hikma Pharmaceuticals plc
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Fresenius Kabi
    • 11.2.4. Sandoz AG
    • 11.2.5. Jubilant Pharma Limited
    • 11.2.6. Baxter
    • 11.2.7. PCI Pharma Services
    • 11.2.8. Gland Pharma Limited (USA)
    • 11.2.9. Dr. Reddy's Laboratories Ltd.
    • 11.2.10. Grand River Aseptic Manufacturing
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us